“An open-label, randomised, parallel clinical research evaluating the safety and efficacy of methotrexate and apremilast in patients with moderate to severe palm plantar psoriasis”., Int. Res. J. Pharm., vol. 15, no. 7, pp. 8–18, Jul. 2027, Accessed: Aug. 01, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/3131